Concentration of Mn-Superoxide Dismutase in Serum in Acute Myocardial Infarction
AkihlkoUsuI,"4KanetusaKato,2HldeyuklTsubol,3TakahltoSone,3HIromISassa,3 and ToshloAbe' Serum concentrations of manganese-containing superoxidedismutase(Mn-SOD; EC 1.15.1.1), a mitochondrial enzyme present in high concentrations in the heart, were measured successively by enzyme immunoassay in 18 patients with acute myocardial infarction (AM I) and in eight with angina pectoris. Results were compared with creatine kinase (EC 2.7.3.2) isoenzyme MB (CK-MB) concentrations in the same specimens. The mean (and SD) serum Mn-SOD concentration in 120 healthy adults was 77.5 (18) g/L. Mn-SOD concentrations exceeding 150 p9/L (>mean + 4 SD) were considered abovenormal. In patients with AMI, the Mn-SOD concentration was 80 (16.8) /L on admission and increased gradually after the first hospital day. The peak, 260 (109) g/L, occurred on the fourth hospital day, at which time the Mn-SOD concentrations in all AMI patients were above normal. Thereafter the Mn-SOD concentration decreased slowly, but still was above normal in 14 of 18 patients on theseventhhospital day.On theotherhand, inpatients with angina pectoris, the Mn-SOD concentration was 78 (11) gIL on admission and did not increase significantly [peak value 97.5 (42) ig/L on the fourth hospital day]. The serum concentration of Mn-SOD is a potentially useful marker for estimating cardiac mitochondrial damage and for diagnosing AMI, especially in the late phase.
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Superoxide dismutase (SOD; EC 1.15.1.1) catalyzes the dismutation of the superoxide anion radical to hydrogen peroxide and oxygen.5 SOD is ubiquitous in oxygen-metabolizing cells, protecting againstoxygen toxicity (1) (2) (3) (4) . Two different forms of SOD predominate in humans, manganese-containing dismutase (Mn-SOD) and copper/zinc-containingdismutase (Cu,Zn-SOD). Mn-SOD is locatedmainly in the matrix of mitochondria, whereas Cu,Zn-SOD is found in the cytoplasm of eukaryotic cells(5-7). Mn-SOD, an 80-kDa tetramer of 196 amino acid residues, is present in high concentration in liver, heart, kidney, and adrenal gland (8) (9) (10) (11) . Heart muscle is rich in Mn-SOD, which is present mainly in the mitochondria.
We hypothesized thatthe Mn-SOD concentrationin serum may change in abbreviations:
SOD, superoxide dismutase; CK-MB, creatine kinase isoenzyme MB; AMI, acute myocardial infarction; AP, angina pectoris; and LDH, lactate dehydrogenase. 
MaterIals and Methods
Eighteenpatients experiencing theirfirst myocardial infarction and eight patients with unstable angina strongly suspicious of AM! were included in this study. The AMI group consisted of 13 men and five women, All subjects were free of hepatic, renal, and neuromuscular disease and were admitted consecutivelyto the coronary care unit of Oogaki MunicipalHospital. Diagnoses were made by the attending cardiologist according to standard criteria, including clinical history, clinical findings, electrocardiographic changes, echocardiographic changes, and biochemical assessments. Serum samples from 120 healthy adults were used as a controlgroup.
Blood samples were collected from the antecubital vein at the following times: (a) on admission to the emergency room; (b) 2, 4, 6, 8, 12 , and 18 h after admission; and (c) on the first, second, third,fourth, fifth, seventh, and tenth days of hospitalization. Serum was obtained by centrifugation (1000 x g, 10 mm) within 30 mm after blood collection and was stored at -80 #{176}C untilanalysis.
Antibodies to human Mn-SOD were raised in Japanese White rabbits by injecting Mn-SOD purified from human liver with Freund's complete adjuvant. Antibodies to Mn-SOD were purified by immunoaflinity chromatography with Mn-SOD-coupled Sepharose 4B (13) (14) (15) .
Mn-SOD concentrations were determined by a sandwich-type enzyme immunoassay system. The assay involves polystyrene balls (3 mm diameter) coated with (12, 16, 17) . CK-MB concentrations were determined in the same samples by the sandwich-type enzyme immunoassay system developed by Kato and ShimIzu (18) . We also measured total CK activity, aspartate aminotransferase concentrations, and lactate dehydrogenase concentrations in the same sample by ultravioletspectrophotometric methods involving creatine phosphate, malate (Figure 1 ).
Results

Serum
Serum Mn-SOD concentrations increased gradually, beginning on the first hospital day, reaching a peak of 260 (SD 109) gfL on the fourth hospital day. Thereafter, concentrations decreased gradually, but were still above normal on the seventhhospital day.
On the otherhand, the serum Mn-SOD concentration in patientswith AP was 78.4 (SD 11.4) pgfL at admissionand subsequently increasedslightly, but not signif- 
Serum CK-MB concentrations in patients.
The serum 0K-MB concentration in patients with AM! was 6.85 (SD 7.35) gfL on admission and increased rapidly, reaching a peak of 148 (SD 80.4) p.gfL 8 h after admission( Figure 2) . Afterwards, the concentration decreased rapidly, and returned to the normal range by the fourth hospitalday. In patientswith AP, the serum CK-MB concentration was 0.94 (SD 0.34) p.g/L on admission and remained within normal limits throughout hospitalization; the highest value noted was 2. 0K-MB concentration already was abnormally high in 11 patients on admission and was above normal in all cases by 4 h after admission. Serum 0K-MB concentrations decreased promptly, and all AMI patients showed normal values by the fourth hospital day. In the AP group, serum 0K-MB concentrations were abnormally high in two patients at the peak (Figure 4 ).
Other serum enzymes in patients withAMl orAP. Total OK activity was above normal in three patients in the AM! group on admission and in two patients on the seventh hospital day but was not increased in any patient at any time in the AP group. Serum concentrations of aspartate aminotransferase were above normal in two patients in the AM! group on admission, in three patients on the seventh hospital day, and in one patient in the AP group during the peak. Serum concentrations of lactate dehydrogenase were above normal in five patients on admission and on the seventh hospital day in the AM! group and in one patient at the peak in the AP group.
DIscussion
The 0K-MB concentration in serum usually is used to estimate the degree of heart damage in patients with AM! (19) . 0K-MB islocalized to the heart and isa specific blood marker for AM!. However, 0K-MB, being a cytoplasmic enzyme, does not reflect cardiac mitochondrial damage. !n looking for an enzyme specific for mitochondria that could be used as a blood marker for cardiac mitochondrial damage, we selected Mn-SOD, which is located predominantly in the mitochondria and is present in the heart in high concentrations (7) (8) (9) (10) (11) . The molecular mass of Mn-SOD is similar to that of 0K-MB (-80 kDa). The clearance mechanism of Mn-SOD from the bloodstream has yet to be determined; 0K-MB is cleared mainly by the reticuloendothelial system (20) . !n the AM! group, serum concentrations of Mn-SOD peaked much later than 0K-MB concentrations and remained abnormally increased, even on the seventh hospital day, after other cardiac markers, e.g., total OK activity and Mn-SOD, an integral part ofmitochondria, isreleased first into the cytoplasm and afterwards into the bloodstream. This may explain why Mn-SOD peaked much later than 0K-MB. These results also suggest that Mn-SOD continues to be released from injured heart muscle for a long time and that the clearance rate of Mn-SOD from the bloodstream may be low.
Serum Mn-SOD concentrations rose slightly in some patients with AP, as did CK-MB concentrations. Presumably, even transient ischemia may injure the myocardium and release small amounts of Mn-SOD and 0K-MB into the bloodstream in patients with AP.
The response of serum Mn-SOD is not as specific as 0K-MB for myocardial damage, because Mn-SOD is ubiquitous.However, the present results suggest that serum Mn-SOD concentrations may be a useful marker for estimating cardiac mitochondrial damage and for diagnosing AM! in the late phase.
